1 / 7

Drug Therapy in Pediatric Patients

Chapter 10. Drug Therapy in Pediatric Patients. Drug Therapy in Pediatric Patients. Pediatrics includes all patients younger than age 16 Pediatric populations have six groups Premature infants (less than 36 weeks gestation) Full-term infants (36 to 40 weeks) Neonates (first 4 weeks)

graham
Télécharger la présentation

Drug Therapy in Pediatric Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 10 Drug Therapy in Pediatric Patients

  2. Drug Therapy in Pediatric Patients • Pediatrics includes all patients younger than age 16 • Pediatric populations have six groups • Premature infants (less than 36 weeks gestation) • Full-term infants (36 to 40 weeks) • Neonates (first 4 weeks) • Infants (5 – 52 weeks) • Children (1 to 12 years) • Adolescents (12 to 16 years)

  3. Pharmacokinetics: Neonates and Infants Infants have five immature pharmacokinetic processes • Drug absorption • Renal excretion • Hepatic metabolism • Protein binding of drugs • Blood-brain barrier

  4. Dosage Determination • Approximate child’s dosage = Body surface area of the child x adult dose 1.73 m²

  5. Dosage Determination (cont.) • Drug dosages are primarily the result of clinical outcome and plasma concentration levels • Compliance is essential for a positive outcome

  6. Compliance • Patient education includes • Dosage size and timing • Route and technique of administration • Duration of treatment • Storage of drug • Desired responses • Adverse responses

  7. Promoting Compliance • Use convenient drug forms • Select dosing times to lifestyle • Mix drugs with foods • Calibrated spoons • Returned demonstrations

More Related